The Inventor of Apple's FaceID Wants to Analyze Your Brain's Health With AI

Summary

Gidi Littwin, co-inventor of FaceID, founded Hemispheric to develop AI for brain health diagnostics. The startup raised $52 million, using data from 100,000 individuals to train models for detecting cognitive disorders. Their first product for PTSD is slated for FDA submission, aiming for public release by 2027.

Key Takeaways

1. Gidi Littwin's startup, Hemispheric, has raised $52 million in funding after gathering data on 100,000 people’s brains to train deep learning models to examine the brain without the need for invasive procedures.
2. The team will submit their first product, which will be used to study PTSD, to the FDA for approval early next year.
3. The future that we envision is one where this is akin to a blood test.

Statement Breakdown

• Claimed Facts: 50% of statements the article presents as facts
• Opinions: 30% of statements classified as editorial or subjective
• Claims: 20% of statements surfaced for additional reader evaluation

Credibility & Bias Reasoning

Credibility assessment: The article presents information from the startup's co-founder and quotes investors, lending it some credibility. However, it relies heavily on the company's claims about future capabilities and FDA approval timelines, which are not yet validated.

Bias assessment: Tech-Optimistic Startup Promotion. The article focuses on the innovative aspects of the technology and the success of the startup's funding round. It highlights the potential benefits and the founders' vision without significant critical examination of challenges or alternative perspectives.

Note: This article highlights a new AI technology for brain health. While promising, the claims about diagnostic accuracy and future widespread use are based on the company's current development stage and future regulatory approvals.

Credibility flag: Promising, but unproven

Claimed Facts (8)

• This states a verifiable fact about the founder's background and the company's objective.
• This provides specific financial and data collection figures for the startup.
• This is a factual statement about the founder's career transition.
• This details the data requirements for previous projects, providing context for Hemispheric's data collection.
• This describes the testing phase and reported outcomes of the AI model.
• This states a specific regulatory milestone and timeline.
• This describes the proposed method of data collection for diagnostic purposes.
• This provides an example of existing AI applications in healthcare.

Opinions (3)

• This is a forward-looking statement expressing a desired outcome and vision for the technology.
• This is an opinion on the limitations of existing EEG devices for current AI applications.
• This expresses a prediction about the future cost and accessibility of the technology.

Claims (5)

• While partially true, this oversimplifies current diagnostic methods which often involve a combination of objective tests and clinical judgment, not solely subjective observations.
• The claim of 'accurate deductions' is presented without specific metrics or independent verification, making it a potentially overconfident assertion.
• This is a claim about ongoing research that has not yet yielded published or independently verified results.
• This describes future capabilities that are still in development and require regulatory approval and clinical validation.
• This is a speculative timeline for public release contingent on FDA approval, which is not guaranteed.

Key Sources

• Gidi Littwin — Co-inventor of FaceID and Vision Pro, Co-founder of Hemispheric
• Hemispheric — AI startup for brain health diagnostics
• Hagai Lalazar — Co-founder of Hemispheric
• WIRED — Media